Biolife Solutions (BLFS) EBITDA Margin (2010 - 2026)
Biolife Solutions (BLFS) reported EBITDA Margin of 0.1% for Q1 2026, up 236.0% year-over-year from 0.03% in Q1 2025, and down 98.63% quarter-over-quarter from 7.17% in Q4 2025.
Biolife Solutions (BLFS) EBITDA Margin (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has 17 years of EBITDA Margin data on file, last reported at 0.1% in Q1 2026.
- EBITDA Margin for Q1 2026 came in at 0.1%, up 236.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 15.39% (down 1325.0% YoY), and the FY2025 annual result was 17.26%, down 1126.0% from the prior year.
- EBITDA Margin slipped to 0.1% in Q1 2026 per BLFS's latest filing, from 7.17% in the prior quarter.
- Over five years, EBITDA Margin peaked at 7.17% in Q4 2025 and troughed at 218.96% in Q4 2022.
- A 5-year average of 47.4% and a median of 22.0% in 2022 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2022 and 2023: EBITDA Margin sank 17429 bps in 2022, then surged 15254 bps in 2023.
- A 5-year view of EBITDA Margin shows it stood at 218.96% in 2022, then jumped by 43 bps to 125.43% in 2023, then surged by 103 bps to 3.59% in 2024, then surged by 100 bps to 7.17% in 2025, then tumbled by 99 bps to 0.1% in 2026.
- Business Quant data shows BLFS's EBITDA Margin at 0.1% in Q1 2026, 7.17% in Q4 2025, and 0.32% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 28.86% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1.97% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 1.63% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 34.92% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 20.96% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 4.04% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -9.90% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 13.65% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.44% |
| 10 | Biolife Solutions | 1.27 Bn | 1.19 Bn | 17.50 Mn | 0.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.10% |
| Dec 31, 2025 | 7.17% |
| Sep 30, 2025 | -0.32% |
| Jun 30, 2025 | -65.47% |
| Mar 31, 2025 | -2.26% |
| Dec 31, 2024 | 3.59% |
| Sep 30, 2024 | -1.95% |
| Jun 30, 2024 | -6.62% |
| Mar 31, 2024 | -17.88% |
| Dec 31, 2023 | -125.43% |
| Sep 30, 2023 | -65.65% |
| Jun 30, 2023 | -36.35% |
| Mar 31, 2023 | -36.08% |
| Dec 31, 2022 | -218.96% |
| Sep 30, 2022 | -28.81% |
| Jun 30, 2022 | -188.89% |
| Mar 31, 2022 | -22.00% |
| Dec 31, 2021 | -49.50% |
| Sep 30, 2021 | -33.01% |
| Jun 30, 2021 | -14.60% |